Log In
CQMS
Make a Donation
Log In
Donate
DONATE OR FUNDRAISE
Donate
Read Roland's story about participating in a prostate cancer trial
Catch up with the news from our 2026 Annual Scientific Meeting
Read about TROG's new President-Elect and Board Members
TROG Research Excellence Award winners announced.
First participant recruited for new lung cancer trial
Secondary Data Analysis grant recipient announced

TROG 01.05 – Superdex/Spinal Cord Compression

Completed
Symptom management

A Pilot Randomised Controlled Trial of Dexamethasone 96mg Versus 16mg Per Day for Malignant Spinal Cord Compression Treated by Radiotherapy - TROG SuperDex Pilot

Primary Sponsor

Trans-Tasman Radiation Oncology Group (TROG)

Clinical Trial Registration

Registration Link

Prev Post

ANZMTG 01.02/TROG 02.01

Next Post

TROG 01.04 – Rectal (Phase III)

Related Post

31 March, 2026

TROG Secondary Data Analysis Grant awarded to project to better understand prostate cancer therapy outcomes

LATEST NEWS: 31 March 2026 TROG’s inaugural Secondary Data

26 March, 2026

TROG welcomes new Board members and President-Elect

LATEST NEWS: 26 March 2026 We are delighted to